| Lymphogranuloma venereum proctocolitis: a silent endemic disease in men who have sex with men in industrialised countries R Martin-Iguacel, JM Llibre, H Nielsen, E Heras, L Matas, R Lugo, B Clotet, ... European journal of clinical microbiology & infectious diseases 29, 917-925, 2010 | 131 | 2010 |
| Risk of cardiovascular disease in an aging HIV population: where are we now? R Martin-Iguacel, JM Llibre, N Friis-Moller Current Hiv/Aids Reports 12, 375-387, 2015 | 89 | 2015 |
| Hypertension is a key feature of the metabolic syndrome in subjects aging with HIV R Martin-Iguacel, E Negredo, R Peck, N Friis-Møller Current hypertension reports 18, 1-14, 2016 | 54 | 2016 |
| Incidence, presentation and outcome of toxoplasmosis in HIV infected in the combination antiretroviral therapy era R Martin-Iguacel, MG Ahlström, M Touma, FN Engsig, NB Stærke, ... Journal of Infection 75 (3), 263-273, 2017 | 41 | 2017 |
| Progressive disseminated histoplasmosis in the HIV population in Europe in the HAART era. Case report and literature review R Martin-Iguacel, J Kurtzhals, G Jouvion, SD Nielsen, JM Llibre Infection 42, 611-620, 2014 | 37 | 2014 |
| Determinants of long-term survival in late HIV presenters: the prospective PISCIS cohort study R Martin-Iguacel, J Reyes-Urueña, A Bruguera, J Aceitón, Y Díaz, ... EClinicalMedicine 52, 2022 | 17 | 2022 |
| How to identify common variable immunodeficiency patients earlier: general practice patterns FV Ilkjær, LD Rasmussen, R Martin-Iguacel, L Westh, TL Katzenstein, ... Journal of Clinical Immunology 39, 641-652, 2019 | 17 | 2019 |
| Incidence of sexually transmitted infections after initiating HIV pre-exposure prophylaxis among MSM in southern Denmark M Azarnoosh, IS Johansen, R Martin-Iguacel American Journal of Men's Health 15 (3), 15579883211018917, 2021 | 15 | 2021 |
| Effectiveness of a treatment switch to Nevirapine plus Tenofovir and Emtricitabine (or lamivudine) in adults with HIV-1 suppressed viremia JM Llibre, I Bravo, A Ornelas, JR Santos, J Puig, R Martin-Iguacel, ... PLoS One 10 (6), e0128131, 2015 | 15 | 2015 |
| Efficacy and safety of switching from enfuvirtide to raltegravir in patients with virological suppression JR Santos, JM Llibre, E Ferrer, P Domingo, A Imaz, J Moltó, ... HIV clinical trials 10 (6), 432-438, 2009 | 15 | 2009 |
| Incidence, clinical presentation, and outcome of HIV-1-associated cryptococcal meningitis during the highly active antiretroviral therapy era: a nationwide cohort study M Touma, LD Rasmussen, R Martin-Iguacel, FN Engsig, NB Stærke, ... Clinical epidemiology, 385-392, 2017 | 13 | 2017 |
| Tuberculosis incidence and mortality in people living with human immunodeficiency virus: a Danish nationwide cohort study R Martin-Iguacel, JM Llibre, C Pedersen, N Obel, NB Stærke, J Åhsberg, ... Clinical Microbiology and Infection 28 (4), 570-579, 2022 | 12 | 2022 |
| The multidisciplinary approach to eosinophilia GN Thomsen, MN Christoffersen, HM Lindegaard, JR Davidsen, ... Frontiers in Oncology 13, 1193730, 2023 | 11 | 2023 |
| Arcobacter butzleri is an opportunistic pathogen: recurrent bacteraemia in an immunocompromised patient without diarrhoea KK Soelberg, TKL Danielsen, R Martin-Iguacel, US Justesen Access Microbiology 2 (8), e000145, 2020 | 9 | 2020 |
| Primary health care: an opportunity for early identification of people living with undiagnosed HIV infection R Martin‐Iguacel, C Pedersen, JM Llibre, J Søndergaard, J Jensen, ... HIV medicine 20 (6), 404-417, 2019 | 9 | 2019 |
| Lymphogranuloma venereum proctocolitis in men with HIV-1 infection E Heras, JM Llibre, E Martro, J Casabona, R Martin-Iguacel, G Sirera Enfermedades Infecciosas y Microbiologia Clinica 29 (2), 124-126, 2011 | 9 | 2011 |
| Prescription of antimicrobials in primary health care as a marker to identify people living with undiagnosed HIV infection, Denmark, 1998 to 2016 R Martin-Iguacel, JM Llibre, J Søndergaard, FV Ilkjær, J Jensen, N Obel, ... Eurosurveillance 24 (41), 1900225, 2019 | 7 | 2019 |
| Mortality and immunovirological outcomes in patients with advanced HIV disease on their first antiretroviral treatment: differential impact of antiretroviral regimens J Burgos, S Moreno-Fornés, J Reyes-Urueña, A Bruguera, ... Journal of Antimicrobial Chemotherapy 78 (1), 108-116, 2023 | 6 | 2023 |
| Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor … H Álvarez, A Mocroft, L Ryom, B Neesgaard, S Edwards, V Svedhem, ... Clinical Infectious Diseases 77 (4), 593-605, 2023 | 5 | 2023 |
| Plasma HIV-1 RNA and CD4⁺ T-cell counts are determinants of virological non-suppression outcomes with initial integrase inhibitor-based regimens: A prospective RESPOND cohort study H Álvarez, A Mocroft, L Ryom, B Neesgaard, S Edwards, VN Svedhem, ... Clinical Infectious Diseases 77 (4), 593-605, 2023 | 5 | 2023 |
